Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05468034 · ClinicalTrials.gov registry record · NA
Exercise in Metastatic Breast Cancer: EMBody
A NA study of Breast Cancer and Indolent Metastatic Breast Cancer, sponsored by Indiana University.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 6
- Study locations
NCT05468034: Recruiting NA study of Breast Cancer and Indolent Metastatic Breast Cancer, sponsored by Indiana University.
NCT05468034 is a NA study of Breast Cancer and Indolent Metastatic Breast Cancer that is actively recruiting participants, run by Indiana University. The registered enrollment target is 100 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower). The trial reports 6 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05468034, a NA study of Breast Cancer and Indolent Metastatic Breast Cancer, is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of this study is to study exercise in a novel population with indolent MBC (no progression on current therapy in prior 12 months and not receiving cytotoxic chemotherapy). The study team hypothesizes that delivering virtual, supervised, progressive intensity aerobic and resistance training exercise for 16 weeks in this population will significantly improve 1) cardiorespiratory fitness, functional status, and sarcopenia (low muscle mass), all established predictors of survival, and 2) patient- reported outcomes.
Primary Outcome
Measured by minutes on the treadmill
Conditions Studied
Interventions
- BEHAVIORAL Exercise Intervention
Study Locations (6)
Indiana
- IU Health West - Avon
- IU Health Joe and Shelly Schwarz Cancer Center - Carmel
- Indiana University Melvin & Bren Simon Cancer Center - Indianapolis
- Sidney and Lois Eskenazi Hospital - Indianapolis
Connecticut
- Yale Cancer Center - New Haven
Massachusetts
- Dana-Farber Cancer Institute - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-04-26 |
| Est. Completion | 2027-12 |
| Phase | NA |
What NCT05468034 shows while recruiting
NCT05468034 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Exercise Intervention is the first listed.
NCT05468034 lists 6 locations in 3 states (Indiana, Connecticut, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT05468034 about?
NCT05468034 is a clinical study titled "Exercise in Metastatic Breast Cancer: EMBody". The purpose of this study is to study exercise in a novel population with indolent MBC (no progression on current therapy in prior 12 months and not receiving cytotoxic chemotherapy). The study team hypothesizes that delivering virtual, supervised, progressive intensity aerobic and resistance traini...
What is the current status of trial NCT05468034?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-04-26. Estimated completion is 2027-12.
What conditions does trial NCT05468034 study?
This clinical trial studies the following conditions: Breast Cancer, Indolent Metastatic Breast Cancer.
What interventions are being tested in trial NCT05468034?
The interventions under investigation include: Exercise Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05468034?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05468034 being conducted?
This trial has 6 study locations across Connecticut, Indiana, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05468034's enrollment target sits among peer trials
100 565th of 1224 higher than 630 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI